What is the catalog number for Phospho-SRC (Y215) Antibody [APR05153G]?

The catalog number for Phospho-SRC (Y215) Antibody [APR05153G] is APR05153G.

What sizes are available for Phospho-SRC (Y215) Antibody [APR05153G]?

Phospho-SRC (Y215) Antibody [APR05153G] is available in the following size(s): 50 µL, 100 µL, 200 µL, 400 µL.

How many pack sizes does Phospho-SRC (Y215) Antibody [APR05153G] come in?

Phospho-SRC (Y215) Antibody [APR05153G] is available in 4 different pack sizes.

Is Phospho-SRC (Y215) Antibody [APR05153G] in stock?

Phospho-SRC (Y215) Antibody [APR05153G] is currently made to order / not held in immediate stock. Contact us for lead time.

Phospho-SRC (Y215) Antibody [APR05153G]

Product Specifications

Background

Tissue Location: Expressed ubiquitously. Platelets, neurons and osteoclasts express 5-fold to 200-fold higher levels than most other tissues

Overview

We constantly strive to ensure we provide our customers with the best antibodies. As a result of this work we offer this antibody in purified format. We are in the process of updating our datasheets. If you have any questions regarding this update, please feel free to contact our technical support team. This product is a high quality Phospho-SRC (Y215) Antibody [APR05153G].

Synonyms

Proto-oncogene tyrosine-protein kinase Src, Proto-oncogene c-Src, pp60c-src, p60-Src, SRC, SRC1

Gene Name

HGNC:11283

Gene ID

6714

UniProt

P12931

Chromosomal Location

Cell membrane; Lipid-anchor. Mitochondrion inner membrane. Nucleus. Cytoplasm, cytoskeleton. Cytoplasm, perinuclear region. Cell junction, focal adhesion. Note=Localizes to focal adhesion sites following integrin engagement (PubMed:22801373) . Localization to focal adhesion sites requires myristoylation and the SH3 domain (PubMed:7525268) . Colocalizes with PDLIM4 at the perinuclear region, but not at focal adhesions (PubMed:19307596)

Applications

WB

Dilution

WB--1:1000

Form

Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.